COSENTYX® (secukinumab) prescribing information (external link)
XOLAIR® (omalizumab) prescribing information (external link)
This page includes promotional content created and funded by Novartis Pharmaceuticals UK Ltd. Novartis products may be mentioned.
Dermatology
COSENTYX® (secukinumab)
SensoReady® 150 mg
injection video
A short video showing you how to prepare and inject Cosentyx with the SensoReady® pen.
UnoReady® 300 mg injection video
A short video showing you how to prepare and inject Cosentyx with the UnoReady® 300mg pen.
Patient case studies with Dr Anthony Abdullah
Digital dosing schedule
Digital dosing schedule
XOLAIR® (omalizumab)
Instruction video for self-injection (pre-filled syringe)
Instruction video for using the Xolair autoinjector
Self-administration starter kit (1): The essentials
Self-administration starter kit (1): The essentials
Self-administration starter kit (2): A guide to self-injection
Self-administration starter kit (2): A guide to self-injection
Self-administration starter kit (3): Things for you to fill in
Self-administration starter kit (3): Things for you to fill in
Self-administration starter kit (4): Important information
Self-administration starter kit (4): Important information
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report, or alternatively email [email protected] or call 01276 698370.
